Skip to content
lifestyle.lamora.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Medicenna Therapeutics Corp.
Medicenna Strengthens U.S. Patent Estate with Newly Issued and Allowed Patents Across its IL-2, IL-4 and IL-13 Superkine Platforms
June 11, 2026
Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026
June 7, 2026
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
June 5, 2026
Medicenna Announces the Launch of a Marketed Public Offering of Securities
June 4, 2026
←
Previous Page
1
2